Cite
HARVARD Citation
Sánchez‐Fdez, A. et al. (2023). The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib. Clinical and translational medicine. 13 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sánchez‐Fdez, A. et al. (2023). The WNK1–ERK5 route plays a pathophysiological role in ovarian cancer and limits therapeutic efficacy of trametinib. Clinical and translational medicine. 13 (4), p. n/a. [Online].